A new global malaria eradication strategy Richard Feachem, Oliver Sabot On Oct 17, 2007, Bill and Melinda Gates called for complete eradication to be adopted as the new goal for the age-old fi ght against malaria, with the Director General of WHO, Margaret Chan, promptly echoing their conviction. Although debate over the wisdom of this target will continue, growing impatience with the low ambitions of current eff orts, fuelled by reductions in morbidity and mortality in some countries 1 and progress in the development of new drugs and the fi rst-ever vaccine, will lead many decision makers to adopt eradication of malaria as the primary aim for their organisations.
Two crucial questions stand out for those organisations that will now begin striving towards malaria eradication. When and how can it be achieved? Barring a magic bullet, which the most promising vaccine candidates are not, 2 even the most optimistic malaria experts agree that eradication is decades away. The latter question, however, requires prompt attention.
If a goal as ambitious as eradication is to be achieved, key groups-including donors, technical agencies, the scientifi c community, and countries where the disease is endemic-must align their energies and resources behind a common approach. That strategy should not be so prescriptive as to prevent appropriate variation among countries and donors, but should provide strong direction to ensure that global investment is well targeted and coordinated. Alternatively, if each donor and agency pursues their own agenda, the momentum gathered over the past 5 years will be lost and the fatalism and inaction that characterised the last decades of the 20th century will return. 3 The malaria community should therefore take immediate steps, including broad debate and detailed technical consultation, to develop a common approach. In November, 2007, the Roll Back Malaria Partnership endorsed the creation of a global malaria business plan to guide collective eradication eff orts. With this Viewpoint, we hope to begin a debate on the strategy that can provide the best overarching framework for that plan and often collective malaria eff orts.
The fi rst global strategy for the fi ght against malaria was adopted in 1955 at the start of the now notorious Global Malaria Eradication Program. This strategy called for massive and rapid application of di chlorodiphenyltrichloroethane (DDT) to interrupt transmission of the disease in countries around the world, regardless of geography and epidemiology (the notable exception was the exclusion of sub-Saharan Africa from this, so called, global strategy). 4 This approach failed to interrupt transmission completely in many countries and malaria resurged to previous or even higher levels as eradication programmes crumbled and the strategy was abandoned. 5 Although no-one will argue for the resurrection of this strategy in full, current impatience has revived interest in rapid indiscriminate attacks to eradicate malaria.
Countries such as Kenya, Rwanda, and Zambia, which generated enthusiasm for an all-out attack with success in reducing malaria mortality by as much as 60%, also show why this strategy would not be advisable. Even if one of these countries did successfully eliminate transmission of malaria, they would fi nd it nearly impossible to sustain, because the parasite would inevitably be reintroduced by migrants and travellers from neighbouring countries with high transmission. Both experience and modelling show us that even a few infections can quickly lead to an epidemic in areas with effi cient vectors and limited protective measures. 5 One of the principal lessons of the fi rst global eradication campaign was that the intensive eff ort needed to prevent resurgence in areas with continued exposure to parasite reservoirs cannot be maintained over time, because fi eld workers tire and lose precision and donors and governments shift resources to seemingly more urgent problems. 6 Thus, even with the large arsenal and war chest available today, an indiscriminate push to eliminate malaria could lead to epidemics and erosion of years of work and investment.
Today's eff orts against malaria target a reduction in malaria mortality through progressive scaling up of a package of interventions. Progress in implementation was at fi rst poor. 7 In the past 3 years, however, many countries have reported more promising results, with steep reductions in morbidity through increased use of insecticide-treated bed nets and other interventions. 8, 9 Seeking to expand this success, a new report launched at the 2008 World Economic Forum in Davos compellingly makes the case for a concerted short-term push to increase coverage of key interventions above 80% and slash morbidity and mortality in malaria-endemic countries. 10 Aggressive scaling up should be the central component of any new strategy, with a dedicated group of well managed professionals helping countries to overcome bottlenecks and to achieve their goal. But the Davos report and other descriptions of this approach leave an essential question unanswered: what happens after aggressive short-term targets are achieved? Maintainence of intensive interventions will be diffi cult once malaria is no longer a major public-health threat and donors and populations lose interest. A breakthrough intervention, such as a highly protective and long-lasting vaccine, will not be available for at least 20 years, while widespread changes in living standards of the sort that contributed to elimination in Europe and the USA will undoubtedly take much longer. 11 Hence, a short-term push must be complemented by a long-term strategy.
In this Viewpoint, we outline a new global malaria strategy with two main components. First, control eff orts would be intensifi ed in the heartland of the malaria endemic-the holoendemic and hyperendemic regions of tropical Africa, Asia, and Latin America. Second, and currently, countries at the margins of the endemic zone would attempt to completely interrupt transmission of the disease at the same time. Over time, as each country eliminates transmission, one or more of their neighbours would begin to pursue elimination with the newly malaria-free area as a foundation, benefi ting from the reductions in transmission achieved by the intensifi ed control eff ort. This process would continue until malaria was eradicated or new technology enabled a shift in strategy.
Malaria has natural margins determined largely by latitude, altitude, climate, and, in some cases, successful human intervention. As latitude and altitude increase, transmission becomes less effi cient and malaria less prevalent. 12 This strategy targets elimination at the current limits of malaria where interruption of transmission is most feasible. The initial target areas, or fronts, could include the southernmost margins of endemic malaria in Africa (Botswana, Namibia, South Africa, and Swaziland), the natural limits of Anopheles mosquitoes in the Pacifi c islands (the Solomon Islands and Vanuatu), and the northernmost malaria margins in Asia (China) and the Americas (southern Mexico). In addition to their epidemiological advantages, the non-Melanesian countries listed have greater wealth and stability and stronger health systems than most malaria-endemic nations. 13 In addition to its technical feasibility, the greatest advantage of pursuing elimination from the margins is the reduced risk of resurgence. Prevention of reintroduction is always challenging, but it is near impossible for a country that has porous borders with several countries with endemic malaria. The countries that would initially target elimination have one or two borders with other malaria endemic areas and commonly have large sections of their territory that are already free of the disease. However, even one border with a malaria-endemic area can undermine elimination, and many of the countries that might be targeted border low-income areas with high malaria transmission. For example, Namibia would have to prevent reintroduction from southern Angola. Eff ectively rising to this challenge will require robust cross-border collaboration. Fortunately, there is a strong incentive for such collaboration: joint investment in malaria control in southern Angola will yield signifi cant returns for both nations. The successful Lubombo Spatial Development Initiative between Mozambique, South Africa, and Swaziland has proven the potency of such collaborations and spurred similar approaches in the region, such as the nascent Trans-Zambezi Initiative. 14, 15 Systematically eliminating malaria from its current margins will gradually expand areas without malaria transmission, freeing millions of people from the threat of infection and death and stimulating investment and tourism. This approach not only makes elimination more feasible to achieve and sustain but also is economically attractive. Large initial investments in elimination would be off set by lower ongoing costs: preventing reintroduction across just one border will cost less than indefi nitely maintaining control interventions at high levels. However, relative cost-eff ectiveness of control and elimination programmes is poorly understood and more robust analysis, taking into account factors such as eff ect on tourism and investment, should be a research priority.
The strategy of gradually eliminating malaria has begun to emerge organically without any signal or recognition from the global community. The Solomon Islands and Vanuatu, with the support from the Australian Government, have recently launched a stepwise approach to interrupt malaria transmission. 16 In March 2007, Ministers of Health from the Southern Africa Development Community approved a new regional malaria strategy that includes a target of eliminating malaria from six member nations by 2015. 17 Interest in and political support for malaria elimination has independently emerged in other countries with favourable conditions, including the Comoros and Madagascar. Irrespective of whether the global community codifi es their actions in an offi cial strategy, these countries should be lauded for their ambition and provided with appropriate support.
The greatest potential shortcoming of this strategy is that donors, attracted by their novelty and ambitious objectives, might invest in elimination programmes at the expense of under-resourced control eff orts. Elimination will always cost more per case than control in an endemic area and will require a portion of the fi nite pool of international support. However, international funding for malaria will probably continue to grow, making potential trade-off s between control and elimination less severe. Furthermore, returns on investment in control will be much lower in the long run in the absence of elimination or another means to consolidate the gains made. As such, the malaria community should focus on the appropriate distribution of resources between both control and elimination rather than either alone, with detailed guidance for donors and countries alike.
This strategy and malaria elimination in resource-poor areas needs more thought and discussion. What interventions should be used in areas with effi cient vectors and weak health systems? How will Plasmodium vivax be eliminated after P falciparum? How can malaria resurgence be eff ectively prevented in sub-Saharan Africa, and how much will this cost? These and many other questions should be answered, drawing on the lessons learned from the fi rst eradication campaign and other experiences. The Malaria Elimination Group, a gathering of international malaria experts convened by the Global Health Group of the University of California, San Francisco, had its fi rst meeting in Santa Cruz, CA, USA, on March 23-26, to explore these questions and to develop a prospectus for malaria elimination. But although important, this process is not suffi cient. An eff ort as large and complex as malaria elimination requires input from many researchers and practitionersinput that is largely absent today. 40 years ago, WHO had 500 staff focusing on malaria elimination 5 -today there is only a handful around the world. This gap must be closed and more resources devoted to research and implementation support for elimination eff orts to be successful. This approach is only one possible path to malaria eradication. We hope that this Viewpoint will inspire debate on the most appropriate strategy to achieve eradication and that others will rapidly come forward with new proposals and evidence. We have left the topic of research largely untouched because it is essential to any strategy that might be adopted. To eradicate malaria, we will need new drugs, insecticides, and other interventions as well as increased understanding of the parasites and vectors. Any fi nal strategy should recognise this crucial role for improved research and provide a framework for how that should be done and fi nanced.
Although a robust strategy is important, the success of malaria eradication will ultimately be determined by fi nancial and political commitment, sound management, and, the work of tens of thousands of individuals around the world. We must, therefore, quickly decide on a new strategy and shift the full attention and resources of the global community to the aggressive implementation of programmes in endemic areas. If we do so with suffi cient courage, conviction, and speed, we may be able to soon resume rolling back the burden of malaria across the world.
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